Amgen Inc(AMGN)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

AMGN iron condor setups AMGN expected move AMGN IV rank history AMGN Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

AMGN $385.16 —
Snapshot
$385.16
After hours $385.16 +0.00%
52-Week Range
$269.77 – $398.00
YTD
+17.56%
IV Rank (30D)
87.3
Straddle Price
$30.82
P/C Vol Ratio
2.40
Market Cap
$209.2B
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.61%
Beta vs SPY1.00
Cost of Equity (CAPM)10.11% (VRP-adj)
WACC9.14%
Volatility Risk Premium+35.1pp (IV − HV30), ERP adj +50bps
Effective Tax Rate14.2%
Rev. Growth (YoY, DCF input)-6.1%
DCF Horizon12 years explicit + fade
Free Cash Flow (TTM)$8.6B
Return on Equity (TTM)84.9%
Book / Price4.4%
Gross Margin (TTM)68.3%
FCF Margin (TTM)23.1%
Debt / Equity5.65
Quality Score4/6 — high quality (12y DCF)
Market-Implied Growth+12.4% (reverse-DCF on current price)
SMA 50$354.63 (Market Anchor value)
SMA 20 / Bollinger Mid$370.21
Bollinger Width / SMA202.8% (drives anchor stability)
Net Debt$39.8B
Market Cap$210B
Peers used for multiples: ABBV, GILD, JNJ, LLY, MRK, REGN, UNH, VRTX
Model Conviction
82%
20-Day Fair Value
≈ by Aug 31, 2026
$392.24
α +1.8% rank 7%
40-Day Fair Value
≈ by Sep 29, 2026
$373.43
α -3.0% rank 7%
60-Day Fair Value
≈ by Oct 28, 2026
$341.79
α -11.3% rank 7%
MethodImplied PriceWeightDetail
DCF $68.15 16%
DDM (Gordon) $71.31 13%
Peer P/E $446.71 7% median 31.1× · 8 peers
Peer EV/EBITDA $477.34 7% median 19.3× · 8 peers
Peer P/B $118.80 1% median 7.0× · 7 peers
Peer P/S $414.24 5% median 6.0× · 8 peers
Market Anchor (SMA50) $354.63 33% stability 100% (BB-width)
Options Expected (B-L 30d) $373.82 16% 45 strikes · skew +0.78
As of 2026-07-31 · updated
Info
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836)
Exchange
XNAS
Market Cap
$209.2B

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthm…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +0.44% 23
Feb -1.51% 23
Mar -0.42% 23
Apr -0.15% 23
May -0.28% 23
Jun +1.15% 23
Jul +7.89% 23
Aug -0.05% 22
Sep -0.13% 23
Oct +0.45% 23
Nov +0.89% 23
Dec +0.20% 23
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $370.76
SMA 50: $355.72
SMA 200: $343.82
Current: $385.19
EMA 12: $377.78
EMA 26: $369.22
MACD: 8.5606 | Signal: 1.5745
BULLISH
ADX (14): 24.37
WEAK TREND
+DI: 28.77
−DI: 15.74
Momentum Oscillators
RSI (14): 64.52
NEUTRAL
Stoch %K: 74.63
Stoch %D: 78.87
Williams %R: -29.08
Volume & Volatility
BB Upper: $391.17
BB Lower: $350.35
NEUTRAL
OBV: 107,762,304
Vol SMA 20: 2,311,265
Vol ROC: -57.93%
ATR: $9.73
True Range: $8.30
HV 20: 25.8%
HV 30: 25.0%
HV 60: 25.2%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-08-01T00:00:00 – 2026-07-30T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

Earnings History
4 of 8 under expected move
Avg Expected Move
4.73%
Avg Actual Move
4.66%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-06 After-Close 5.46% 3.65% 0.67x Within
2024-10-30 After-Close 5.19% 2.39% 0.46x Within
2025-02-04 After-Close 4.51% 8.05% 1.78x Exceeded
2025-05-01 After-Close 4.53% 1.12% 0.25x Within
2025-08-05 After-Close 4.74% 5.13% 1.08x Exceeded
2025-11-04 After-Close 4.62% 4.53% 0.98x Within
2026-02-03 After-Close 4.33% 7.64% 1.76x Exceeded
2026-04-30 After-Close 4.49% 4.75% 1.06x Exceeded
Options Activity
IV Rank (30D)
87.3
IV Rank (7D)
100
Avg IV
61.7%
Straddle (30D)
$30.82
Straddle (7D)
$22.10
P/C Volume
2.40
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.43
Correlation (SPY)
20.3%
R²
0.04
Ann. Volatility
27.4%
SPY Volatility
12.9%

Low volatility - stock moves less than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30
Diluted shares outstanding: 542,250,000 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

3,220 filers435,635,831 shares$147.27B value80.34% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 54,838,826 $17.95B 12.19% 10.11% 2025-12-31
2 BlackRock, Inc. Custodian 47,100,472 $16.57B 11.25% 8.69% 2026-03-31
3 STATE STREET CORP 30,548,488 $10.75B 7.30% 5.63% 2026-03-31
4 Capital World Investors 29,288,343 $10.30B 7.00% 5.40% 2026-03-31
5 GEODE CAPITAL MANAGEMENT, LLC Custodian 15,430,524 $5.41B 3.68% 2.85% 2026-03-31
6 MORGAN STANLEY Custodian 15,744,528 $5.15B 3.50% 2.90% 2025-12-31
7 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 12,773,386 $4.49B 3.05% 2.36% 2026-03-31
8 Invesco Ltd. 11,313,781 $3.98B 2.70% 2.09% 2026-03-31
9 PRIMECAP MANAGEMENT CO/CA/ 8,874,129 $3.12B 2.12% 1.64% 2026-03-31
10 JPMORGAN CHASE & CO Custodian 7,277,837 $2.54B 1.72% 1.34% 2026-03-31
11 Capital International Investors 7,122,275 $2.51B 1.70% 1.31% 2026-03-31
12 WELLS FARGO & COMPANY/MN Custodian 7,088,010 $2.49B 1.69% 1.31% 2026-03-31
13 Capital Research Global Investors 6,955,345 $2.45B 1.66% 1.28% 2026-03-31
14 NORTHERN TRUST CORP Custodian 6,217,838 $2.19B 1.49% 1.15% 2026-03-31
15 BANK OF AMERICA CORP /DE/ Custodian 5,121,028 $1.80B 1.22% 0.94% 2026-03-31
16 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME Custodian 4,784,982 $1.68B 1.14% 0.88% 2026-03-31
17 ROYAL BANK OF CANADA Custodian 4,471,445 $1.57B 1.07% 0.82% 2026-03-31
18 GOLDMAN SACHS GROUP INC Custodian 4,219,989 $1.48B 1.01% 0.78% 2026-03-31
19 Legal & General Group Plc Custodian 3,870,863 $1.36B 0.92% 0.71% 2026-03-31
20 Bank of New York Mellon Corp Custodian 3,793,443 $1.33B 0.91% 0.70% 2026-03-31
21 FMR LLC Custodian 3,776,430 $1.33B 0.90% 0.70% 2026-03-31
22 Amundi Custodian 3,377,306 $1.19B 0.81% 0.62% 2026-03-31
23 DIMENSIONAL FUND ADVISORS LP Custodian 3,304,344 $1.16B 0.79% 0.61% 2026-03-31
24 UBS Group AG Custodian 3,148,040 $1.11B 0.75% 0.58% 2026-03-31
25 Aristotle Capital Management, LLC 3,079,565 $1.08B 0.74% 0.57% 2026-03-31
59 filers$1.95B notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $360.89M 18.52% 2026-03-31
2 JANE STREET GROUP, LLC Custodian $326.69M 16.77% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $261.60M 13.43% 2026-03-31
4 GROUP ONE TRADING LLC Custodian $189.68M 9.74% 2026-03-31
5 MILLENNIUM MANAGEMENT LLC Custodian $87.68M 4.50% 2026-03-31
6 BARCLAYS PLC Custodian $75.47M 3.87% 2026-03-31
7 PEAK6 LLC $68.51M 3.52% 2026-03-31
8 IMC-Chicago, LLC Custodian $63.68M 3.27% 2026-03-31
9 WOLVERINE TRADING, LLC Custodian $47.31M 2.43% 2025-09-30
10 Walleye Trading LLC $41.98M 2.15% 2026-03-31
11 D. E. Shaw & Co., Inc. Custodian $33.95M 1.74% 2026-03-31
12 SIMPLEX TRADING, LLC Custodian $31.60M 1.62% 2026-03-31
13 BNP PARIBAS FINANCIAL MARKETS Custodian $28.57M 1.47% 2026-03-31
14 Alphadyne Asset Management LP $27.69M 1.42% 2026-03-31
15 Qube Research & Technologies Ltd $26.18M 1.34% 2026-03-31
16 JPMORGAN CHASE & CO Custodian $25.93M 1.33% 2026-03-31
17 Squarepoint Ops LLC $23.96M 1.23% 2026-03-31
18 UBS Group AG Custodian $22.94M 1.18% 2026-03-31
19 CITIGROUP INC Custodian $20.06M 1.03% 2026-03-31
20 GOLDMAN SACHS GROUP INC Custodian $18.89M 0.97% 2026-03-31
21 Centiva Capital, LP $17.59M 0.90% 2026-03-31
22 NATIONAL BANK OF CANADA /FI/ Custodian $16.01M 0.82% 2026-03-31
23 CAPITAL FUND MANAGEMENT S.A. $14.50M 0.74% 2026-03-31
24 Eisler Capital Management Ltd. $12.84M 0.66% 2025-09-30
25 Walleye Capital LLC $11.58M 0.59% 2026-03-31
52 filers$1.53B notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $280.64M 18.38% 2026-03-31
2 JANE STREET GROUP, LLC Custodian $229.93M 15.06% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $216.56M 14.18% 2026-03-31
4 MILLENNIUM MANAGEMENT LLC Custodian $96.44M 6.32% 2026-03-31
5 Centiva Capital, LP $89.86M 5.89% 2026-03-31
6 IMC-Chicago, LLC Custodian $50.74M 3.32% 2026-03-31
7 GOLDMAN SACHS GROUP INC Custodian $50.53M 3.31% 2026-03-31
8 WOLVERINE TRADING, LLC Custodian $50.16M 3.29% 2025-09-30
9 Alphadyne Asset Management LP $39.69M 2.60% 2026-03-31
10 Qube Research & Technologies Ltd $37.19M 2.44% 2026-03-31
11 BNP PARIBAS FINANCIAL MARKETS Custodian $37.16M 2.43% 2026-03-31
12 BALYASNY ASSET MANAGEMENT L.P. $32.05M 2.10% 2026-03-31
13 JPMORGAN CHASE & CO Custodian $29.94M 1.96% 2026-03-31
14 Eisler Capital Management Ltd. $25.60M 1.68% 2025-09-30
15 Walleye Trading LLC $24.21M 1.59% 2026-03-31
16 HSBC HOLDINGS PLC Custodian $23.47M 1.54% 2026-03-31
17 CAPSTONE INVESTMENT ADVISORS, LLC $22.03M 1.44% 2026-03-31
18 UBS Group AG Custodian $21.85M 1.43% 2026-03-31
19 GROUP ONE TRADING LLC Custodian $21.11M 1.38% 2026-03-31
20 CAPITAL FUND MANAGEMENT S.A. $17.87M 1.17% 2026-03-31
21 SIMPLEX TRADING, LLC Custodian $17.17M 1.12% 2026-03-31
22 BARCLAYS PLC Custodian $14.36M 0.94% 2026-03-31
23 Allianz Asset Management GmbH $14.00M 0.92% 2026-03-31
24 NOMURA HOLDINGS INC $10.06M 0.66% 2026-03-31
25 CITIGROUP INC Custodian $8.44M 0.55% 2026-03-31
Insider Activity
Latest: 2026-05-21
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-05-21 Wanda M Austin Director Award (A) +665 — EDGAR
2026-05-21 Michael V Drake Director Award (A) +665 — EDGAR
2026-05-21 Brian Druker Director Award (A) +665 — EDGAR
2026-05-21 ROBERT ECKERT Director Award (A) +665 — EDGAR
2026-05-21 Greg C. Garland Director Award (A) +665 — EDGAR
2026-05-21 CHARLES M HOLLEY Director Award (A) +665 — EDGAR
2026-05-21 OMAR ISHRAK Director Award (A) +665 — EDGAR
2026-05-21 Tyler Jacks Director Award (A) +665 — EDGAR
2026-05-21 Mary E. Klotman Director Award (A) +665 — EDGAR
2026-05-21 Ellen Jamison Kullman Director Award (A) +665 — EDGAR
2026-05-21 AMY E MILES Director Award (A) +665 — EDGAR
2026-05-11 James E. Bradner EVP, Research and Development Tax (F) −446 $331.11 -$147.7K EDGAR
2026-05-11 Robert A Bradway Chairman, CEO and President Tax (F) −2,079 $331.11 -$688.4K EDGAR
2026-05-11 Murdo Gordon EVP, Global Commercial Ops Tax (F) −615 $331.11 -$203.6K EDGAR
2026-05-11 Jonathan P Graham EVP & Gen. Counsel & Sec. Tax (F) −499 $331.11 -$165.2K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
60 insiders · @ $385.19
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Robert A Bradway Chairman, CEO and President 565,220 $217.72M -$6.29M 94 2026-05-11
2 ANTHONY C HOOPER EVP, Global Commercial Ops. 215,147 $82.87M $0 34 2018-05-07
3 FABRIZIO BONANNI EVP, Operations 206,001 $79.35M -$35.90M 30 2012-07-31
4 ROGER M PERLMUTTER EVP, Research & Development 186,031 $71.66M -$9.58M 18 2012-02-06
5 GILBERT S OMENN Director 178,669 $68.82M -$3.19M 19 2013-04-30
6 GEORGE J MORROW Exe VP, Global Commercial Ops 134,606 $51.85M -$4.06M 15 2010-04-30
7 DENNIS M FENTON Executive V.P., Operations 134,186 $51.69M -$858.9K 5 2007-06-05
8 BRIAN M MCNAMEE EVP 102,516 $39.49M -$26.83M 65 2017-05-03
9 KEVIN W SHARER Chairman of the Board and CEO 101,018 $38.91M -$131.49M 34 2012-10-26
10 DAVID J SCOTT SVP, Gen. Counsel & Secy. 95,018 $36.60M -$22.28M 41 2015-04-28
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-05-04
Last 30d: 0 filings  ·  Last 90d: 1 filing · $400K notice value · 1 unique filer

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: Grygiel Nancy A. (1, $400K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-05-04 Grygiel Nancy A. Officer 1,237 $400.4K 2026-05-04 Raymond James & Associates — EDGAR
2026-02-27 Santos Esteban Associate 54,792 $20.77M 2026-02-26 Pershing Advisor Solutions — EDGAR
2026-02-19 Busch Matthew C. ASSOCIATED TO AFFILIATE 1,000 $375.0K 2026-02-19 FIDELITY BROKERAGE SERVICES LLC — EDGAR
2025-11-20 Grygiel Nancy A. Officer 3,139 $1.06M 2025-11-20 Raymond James & Associates — EDGAR
2025-11-12 Khosla Rachna Officer 890 $300.3K 2025-11-12 Fidelity Brokerage Services LLC — EDGAR
2025-11-12 Gordon Murdo Officer 6,879 $2.32M 2025-11-12 Charles Schwab Corporation — EDGAR
2025-08-20 Grygiel Nancy A. Officer 1,267 $372.9K 2025-08-20 Raymond James & Associates — EDGAR
2025-06-05 Khosla Rachna Officer 1,500 $435.0K 2025-06-05 Fidelity Brokerage Services LLC — EDGAR
2025-05-02 Busch Matthew C. Officer 1,000 $281.4K 2025-05-02 FIDELITY BROKERAGE SERVICES LLC — EDGAR
2025-02-21 DAVID M REESE & JOAN I CHUCO-TTEE CHU-REESE FAMILY TRUSTU/A DTD 01/07/2005 Officer 25,225 $7.68M 2025-02-21 Morgan Stanley Smith Barney LLC … — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
Recent SEC Filings
Latest: 2026-05-20
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-20 0001193125-26-232786 EDGAR
2026-05-19 0000318154-26-000097 EDGAR
2026-04-30 0000318154-26-000054 EDGAR
2026-04-22 0000318154-26-000048 EDGAR
2026-02-19 0001193125-26-059490 EDGAR
2026-02-03 0000318154-26-000003 EDGAR
2026-01-30 0001193125-26-030518 EDGAR
2025-11-04 0000318154-25-000070 EDGAR
2025-08-05 0000318154-25-000054 EDGAR
2025-05-27 0000950170-25-077233 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-13 0000318154-26-000010 EDGAR
2025-02-14 0000318154-25-000010 EDGAR
2024-02-14 0000318154-24-000011 EDGAR
2023-02-09 0000318154-23-000017 EDGAR
2022-02-16 0000318154-22-000010 EDGAR
2021-02-09 0000318154-21-000010 EDGAR
2020-02-12 0000318154-20-000017 EDGAR
2019-02-13 0000318154-19-000008 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-01 0000318154-26-000057 EDGAR
2025-11-05 0000318154-25-000072 EDGAR
2025-08-06 0000318154-25-000056 EDGAR
2025-05-02 0000318154-25-000020 EDGAR
2024-10-31 0000318154-24-000044 EDGAR
2024-08-07 0000318154-24-000035 EDGAR
2024-05-03 0000318154-24-000020 EDGAR
2023-10-31 0000318154-23-000064 EDGAR
2023-08-04 0000318154-23-000053 EDGAR
2023-04-28 0000318154-23-000029 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/E Ratio26.8
P/B Ratio22.8
P/S Ratio5.6
EV/EBITDA16.5
TTM Revenue$37.2B
TTM Net Income$7.8B
TTM EPS$14.38
ROE84.9%
Dividend Yield2.49%
Debt/Equity6.24